Cazorla, Maxime

Identification of a low–molecular weight TrkB antagonist with anxiolytic and antidepressant activity in mice

Cazorla, M., Prémont, J., Mann, A., Girard, N., Kellendonk, C., & Rognan, D. (2011) · Journal of Clinical Investigation

Treatment of Major DepressionNerve injury and regeneration

Cited by 392

Dopamine D2 receptors regulate the anatomical and functional balance of basal ganglia circuitry

Cazorla, M., de Carvalho, F. D., Chohan, M. O., Shegda, M., Chuhma, N., Rayport, S., Ahmari, S. E., Moore, H., & Kellendonk, C. (2014) · Neuron

Neurotransmitter Receptor Influence on BehaviorNeuroscience and Neuropharmacology Research

Cited by 226

Cyclotraxin-B, the First Highly Potent and Selective TrkB Inhibitor, Has Anxiolytic Properties in Mice

Cazorla, M., Jouvenceau, A., Rose, C., Guilloux, J.-P., Pilon, C., Dranovsky, A., & Prémont, J. (2010) · PLoS ONE

Nerve injury and regenerationTreatment of Major Depression

Cited by 99

TrkB inhibition as a therapeutic target for CNS-related disorders

Boulle, F., Kenis, G., Cazorla, M., Hamon, M., Steinbusch, H. W. M., Lanfumey, L., & van den Hove, D. L. A. (2012) · Progress in Neurobiology

Nerve injury and regenerationComputational Drug Discovery Methods

Cited by 80

Pharmacological characterization of six trkB antibodies reveals a novel class of functional agents for the study of the BDNF receptor

Cazorla, M., Arrang, J., & Prémont, J. (2011) · British Journal of Pharmacology

Nerve injury and regenerationPain Mechanisms and Treatments

Cited by 35